|
Re: FDA meeting confirmed
|
6
|
Resverlogix Corp.
|
Jun 10, 2020 11:26AM
|
|
Re: FDA meeting confirmed
|
2
|
Resverlogix Corp.
|
Jun 10, 2020 11:32AM
|
|
Re: FDA grants Fast Track designation to Jardiance for the treatment of CKD
|
5
|
Resverlogix Corp.
|
Mar 15, 2020 12:24PM
|
|
Re: FDA grants Fast Track designation to Jardiance for the treatment of CKD
|
5
|
Resverlogix Corp.
|
Mar 15, 2020 03:01PM
|
|
Re: FDA grants Fast Track designation to Jardiance for the treatment of CKD
|
1
|
Resverlogix Corp.
|
Mar 15, 2020 03:30PM
|
|
Re: Fair warning to everyone here....
|
5
|
Resverlogix Corp.
|
Jun 25, 2019 08:37AM
|
|
Re: Extension of debenture!
|
3
|
Resverlogix Corp.
|
Apr 20, 2022 06:22AM
|
|
Re: Expected Results
|
5
|
Resverlogix Corp.
|
Jan 23, 2022 11:12AM
|
|
Re: Expected and unexpected....
|
3
|
Resverlogix Corp.
|
Apr 06, 2019 08:42AM
|
|
Re: Expectations
|
4
|
Resverlogix Corp.
|
Sep 17, 2019 02:54PM
|
|
Re: Exercise of options Norma Biln
|
4
|
Resverlogix Corp.
|
Jul 29, 2020 02:07PM
|
|
Re: Exercise of options Norma Biln
|
3
|
Resverlogix Corp.
|
Jul 29, 2020 09:42AM
|
|
Re: Exceptionally good news
|
5
|
Resverlogix Corp.
|
Nov 18, 2019 11:25AM
|
|
Re: Exceptionally good news
|
7
|
Resverlogix Corp.
|
Nov 18, 2019 11:59AM
|
|
Re: Eversana ValuationCaseStudy
|
10
|
Resverlogix Corp.
|
Jan 08, 2022 11:30AM
|
|
Re: Eversana ValuationCaseStudy
|
9
|
Resverlogix Corp.
|
Jan 08, 2022 01:18PM
|
|
Re: Eversana ValuationCaseStudy
|
10
|
Resverlogix Corp.
|
Jan 09, 2022 12:37PM
|
|
Re: Eversana
|
13
|
Resverlogix Corp.
|
Jul 08, 2021 08:16AM
|
|
Re: Ethics
|
4
|
Resverlogix Corp.
|
May 13, 2021 10:46PM
|
|
Re: ESC Wrap Up for Sunday Sept 1....
|
5
|
Resverlogix Corp.
|
Sep 02, 2019 11:14AM
|
